Decreased monocyte antibody-dependent cell-mediated toxicity in stage I?II malignant melanoma

Rapid identification of monocytes in a mixed mononuclear cell preparation

1977 • 330 citations

Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvum

1966 • 270 citations

Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

1973 • 221 citations

Corynebacterium parvum as a Therapeutic Antitumor Agent in Mice. II. Local Injection 2

1974 • 98 citations

Abnormalities of Monocyte Chemotaxis in Patients With Melanoma: Effects of Immunotherapy and Tumor Removal2

1977 • 97 citations

Characterization of Glass Adherent Human Mononuclear Cells

1973 • 94 citations

A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I):Prognostic factors analysis and preliminary results of immunotherayp

1982 • 70 citations

[STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM].

1964 • 65 citations

Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity.

1978 • 56 citations

Human lymphocyte, monocyte, and neutrophil antibody-dependent cell-mediated cytotoxicity toward human erythrocytes

1978 • 36 citations

Monocyte-mediated antibody-dependent cell-mediated cytotoxicity: the role of the metabolic burst

1981 • 31 citations

Monocytes and macrophages in malignant melanoma. II. Lysis of antibody-coated human erythrocytes as an assay of monocyte function

1978 • 31 citations

Monocyte dysfunction in human cancer

1983 • 29 citations

A prospective study of immune responsiveness in human melanoma.I. Assessment of initial pretreatment status with stage of disease

1978 • 28 citations

Surgical adjuvant therapy of malignant melanoma withCorynebacterium parvum

1981 • 27 citations

Discordance among Cell-Mediated Cytolytic Mechanisms in Cancer Patients: Importance of the Assay System

1979 • 26 citations

Effect of Immunomodulators on Effector Cells Involved in Antibody-Dependent Cellular Cytotoxicity: Brief Communication2

1977 • 23 citations

Antibody-dependent cell-mediated cytotoxicity in human cancer: Characterization of patient leukocyte activity and treatment effects

1982 • 21 citations

Antibody-dependent cell-mediated cytotoxicity in treated and nontreated cancer patients

1977 • 21 citations

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.

1979 • 20 citations

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.

1979 • 11 citations

Immunologic function during adjuvant BCG immunotherapy for malignant melanoma: Induction of anergy

1979 • 8 citations

Monocyte function in patients with solid neoplasms during immunotherapy withCorynebacterium parvum

1978 • 8 citations

Effect of BCG on monocyte-mediated antibody-dependent cellular cytotoxicity in stage I melanoma

1980 • 5 citations

Inefficacy of sc Corynebacterium parvum in stage I malignant melanoma: preliminary results of a single-institution pilot study.

1983 • 4 citations